Navigation Links
Tetanus toxin found to have therapeutic properties

A team of researchers from the Department of Biochemistry and Molecular Biology and the Institute of Neuroscience at the Universitat Autònoma de Barcelona has discovered that tetanus toxin, which causes tetanus, could be extremely useful as a therapy against psychological disorders such as depression, anxiety and anorexia, and to slow the progress of neurodegenerative disorders such as Parkinson's disease.

Tetanus toxin is a neurotoxin belonging to the same family as botulinum neurotoxins, which cause botulism. These have been successfully used as a therapy to treat disorders caused by abnormal muscular contractions such as strabismus, cerebral palsy, anal contractions and torticollis. Recently these toxins have been used even in cosmetics against wrinkles. For these therapeutic and cosmetic applications, the scientists are working with sublethal doses of toxins.

Led by José Aguilera, scientists from the Department of Biochemistry and Molecular Biology and the Institute of Neuroscience at the UAB, have studied whether it would also be possible to use sublethal doses of tetanus toxin and molecules derived from tetanus toxin for therapeutic purposes. The results have been obtained in the laboratory after 20 years of studying these toxins, and they are very encouraging.

Two separate, distinct parts form the tetanus toxin molecule: one part is the cause of the toxic effects and the tetanus symptoms; the other, however, is harmless and is able to penetrate and affect the nervous system. This harmless part, called the carboxy-terminal domain, has been reproduced in large quantities in the laboratory so that tests can be carried out on its effects on the nervous system of rats.

The experiments have shown that the harmless part inhibits serotonin from being transported through the synaptic membranes, i.e. the membranes that connect the neurones so that signals can be sent through the brain. The molecule is as effective as the selective inhibit
'"/>

Source:Universitat Autonoma de Barcelona


Page: 1 2

Related biology news :

1. Defensins neutralize anthrax toxin
2. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
3. Structures of marine toxins provide insight into their effectiveness as cancer drugs
4. Prenatal exposure to marine toxin causes lasting damage
5. UCSD study finds anthrax toxins also harmful to fruit flies
6. Scientists design potent anthrax toxin inhibitor
7. Anthrax inhibitor counteracts toxin, may lead to new therapeutics
8. Scientists reveal how deadly toxin hijacks cells
9. Scientists develop a way to make the deadliest toxin known even more toxic
10. Yale researchers find environmental toxins disruptive to hearing in mammals
11. Evolution mystery: Spider venom and bacteria share same toxin

Post Your Comments:
(Date:11/4/2009)..., N.Y., Oct. 21 What,s the cost of...g accidental death resulting from prescription med...good intentions, however, may be unaware that the ...eir teens from the ticking timebomb of prescriptio...in premium-quality medical supplies, has formed an...
(Date:11/4/2009)...APEL HILL Scientists at the University of North C...University of California, San Francisco have devel...ict new target diseases for existing drugs. , Th...t compares how similar the structures of all known...ners -- known as ligands -- of disease targets wit...
(Date:11/3/2009)... RATON, FL (November 4, 2009) For more than 25 ye...en conch ( Strombus gigas ) have been unsuccessful...ry seeding techniques to produce beaded (nucleated...nch have been developed by scientists from Florida... Institute (HBOI). With less than two years of res...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3HPV vaccine could prevent breast cancer 3A Australian research 56154 1HPV vaccine could prevent breast cancer 3A Australian research 56154 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 1Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 3NIBIB scientists increase imaging efficiency in cell structure studies 56150 1NIBIB scientists increase imaging efficiency in cell structure studies 56150 2
...single vaccine could be used to protect chickens, ...rding to an article published in the November issu...e protects birds and mammals against different flu... are still in their eggs, allowing the mass vaccin...has posed a major challenge to scientists designin...
...In a disease like ALS - one that,s always fatal an...ology - finding a proof of principle in animal mod...searchers report that transplanting a new line of ...e clearly shifts key signs of neurodegenerative di...he animals, neuron loss and extending life. , The...
...searchers at Emory University and Georgia Institut...that can slowly release anti-inflammatory drugs an...jected into rats, hearts after a simulated heart a...nflammation and scarring, the researchers found.,I...tissue formed after the heart attack in half and b...
Other Biology News:Bird flu vaccine protects people and pets 2Swamping bad cells with good in ALS animal models helps sustain breathing 2Swamping bad cells with good in ALS animal models helps sustain breathing 3Drug-embedded microparticles bolster heart function in animal studies 2
(Date:11/7/2009)...v. 7, Research projects in the are...s this evening, as Tim Kunisky of Livingston, NJ a...of Audubon, PA received the highest honors at the ... in Math, Science & Technology, the nation,s p...ttp://www.newscom.com/cgi-bin/prnh/20070904/SIEMEN...
(Date:11/6/2009).... 6 Helix BioPharma Corp...ounced that John Docherty, president and chief ope...rd,s 6th annual Investor Summit on November 10, 20...y. Mr. Docherty will provide an overview of the C...S47 and Topical Interferon Alpha-2b. The slide sh...
(Date:11/6/2009)...ov. 6 ,, 3Q09 Corp...utenza(TM) E.U. Marketing Authorization to Astella...n commercial readiness activities Expanded manage...rketing; and Director, Commercial Operations Appo... Audit Committee chairman , Upcoming 2009 M...
(Date:11/6/2009).... 6 Intarcia Therapeutics, Inc. de...UROS® continuous delivery of exenatide) progr...th Annual Diabetes Technology Meeting in San Franc...-bin/prnh/20050301/SFTU126LOGO ) ,, Continuou...Lowers Plasma Glucose, HbA1c and Reduces Weight in...
Breaking Biology Technology:Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 2Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 3Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 4Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 5Mathematics and Biochemistry Research Earn Top Prize at Nation's Premier High School Science Competition 6Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5
...ideas passed muster in the first round of the Gove...ednesday. , ,They were chosen from 188 submissions...their businesses and represent various municipalit...kee areas. , ,That,s down from 200 entries last ye...gher, chairman of the Wisconsin Technology Council...
...in break Thursday at the Milwaukee County Grounds ...iday to 37 companies in the Milwaukee County Resea...rks director of development said businesses in the...nconvenience. , ,Guy T. Mascari, whose office is l...ation Center, said the center is the only building...
...lor of research in the history of the University o...ng to change its image from a university of access...elp Milwaukee build a knowledge-based economy. , ,...Wisconsins 2006 Technology Achievement Awards, app...ive. Citing Atlanta as a potential model, he said ...
Other Biology Technology:Tech awards keynoter asks for support of UWM transformation 2Tech awards keynoter asks for support of UWM transformation 3
...onoclonal [198C679.2.1] to Presenilin 2 Alzheimer... the disease carry mutations in the presenilin pro...ein (APP). These disease-linked mutations result i...id-beta (main component of amyloid deposits found ...
CryoPlus Square Rack, CP-13-2-CW/100, 27-11/32" OAH from Thermo Scientific
Goat Anti-Human Glypican 2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Beta 2-Microglobulin ELISA Kit from Biomeda Corporation
Biology Products: